Pure Global
NCT06083311

The Efficacy of a Probiotic for Functional Constipation (FC)

A Randomised, Triple-blinded, Placebo-controlled, Parallel Group Pilot Study, to Assess the Effect of Probiotic on Functional Constipation and Gut Microbiology
The Archer-Daniels-Midland Company·ClinicalTrials.gov·dietary supplementRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Functional Constipation
Drug/Device/Intervention
Probiotic
Study type
Interventional
Intervention type
dietary supplement
Sponsor & location
Primary sponsor
The Archer-Daniels-Midland Company
Location
Berlin, Germany
Timeline & enrollment
Phase
N/A
Start date
Oct 19, 2023
End date
Sep 01, 2024
Enrollment
100 participants
Primary outcome

Difference in change in Cleveland Clinic Constipation score (total) from baseline (V2) to study end (V3)

Summary

Investigate the effect of a probiotic (live bacteria) in individuals with functional
 constipation.

ICD-10 classifications
ConstipationOther functional intestinal disordersFunctional intestinal disorder, unspecifiedOther specified functional intestinal disordersOther laxatives
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06083311
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06083311 through Pure Global AI's free database. This phase not specified trial is sponsored by The Archer-Daniels-Midland Company and is currently Recruiting. The study focuses on Functional Constipation. Target enrollment is 100 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.